Option chain shows key data for Medley Management's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Medley Management.

Medley Management (OTC:MDLM) Stock, Option Chain

Medley Management Inc is an asset management company providing its services mainly to retail and institutional investors. It provides credit-focused investment strategies through various funds and products that meet the needs of a wide range of retail and institutional investors. The company manages two permanent capital vehicles, both of which are business development companies, as well as long-dated private funds and separately managed accounts. The company focuses on credit-related investment strategies originating senior secured loans to private middle-market companies in the United States. The company recognizes most of its revenues through management fees.

MEDLEY MANAGEMENT A by Medley Management, Inc.

Medley Management Inc

Tech stocks began Christmas week with positive momentum, as the Nasdaq 100 rose 0.4% on Monday, building on a 0.7% gain from Friday. The index has now recovered nearly half of the losses sustained following the <a href="https://www.benzinga.com/topic/federal-reserve">Federal Reserve's recent policy meeting.</a>
Semiconductors stood out as the top-performing sector:
<ul>
<li>iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) jumping 2.3%.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), up 4.7%</li>
<li>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), which surged 4.9%.</li>
</ul>
Meanwhile, other major indices showed minimal movement in what appeared to be a session marked by low trading volumes.
Consumer staples emerged as the weakest sector, with notable declines in major retailers. Dollar General Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) dropped 3.3%, while Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) shed 2.8%. 
In economic news, U.S. consumer confidence fell sharply in December, with the index dropping 8.1 points to 104.7 amid worsening expectations in future economic conditions.
The U.S. dollar index edged higher, mirroring a further surge in Treasury yields. The yield on the 10-year Treasury note rose 4 basis points to 4.57%, approaching its highest closing level since late May.
In commodities, gold slipped 0.4%, set to break a two-session winning streak, while oil prices declined 1%.
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 1.7% to around $93,000, eyeing its fifth loss in the past six sessions.
Shares of MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) tumbled over 4% in their first trading session after the company's inclusion in the Nasdaq 100 index.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,373.71</td>
<td>0.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,932.42</td>
<td>0.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,232.71</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,620.75</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:30 p.m. ET </figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) edged 0.1% higher to $592.12.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.4% to $427.22.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.4% to $520.67.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.4% to $221.06.</li>
<li>The&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up by 0.5%; the&nbsp;Consumer Staples Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) lagged, down 2%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) rose 3% following a 17.8% drop on Friday. The U.S. Food and Drug Administration announced on Monday that it has approved Hikma Pharmaceuticals&#8217; generic version of Novo Nordisk&#8217;s Victoza for treating type 2 diabetes.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) rallied 18%, after Stifel raised the stock price target from $16 to $18. </li>
<li>Carnival Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) fell over 4% following a 6.4% post-earning rally Friday. </li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42653753/history-may-hint-at-sp-500-struggles-in-2025-yet-there-is-also-hope-heres-why">History Suggests S&amp;P 500 Could Struggle In 2025, But There&#8217;s Reason For Optimism</a></li>
</ul>
Image: Shutterstock

Tech

$BTC

AVGO

SPDR Dow Jones Industrial Average ETF Trust

MSTR

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

XLRE

Tech Stocks Eye Christmas Gains, Microstrategy Tumbles As Bitcoin Dips To $93,000: What's Driving Markets Monday?

Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>), a clinical-stage biotechnology company that develops therapeutics using its INTASYL&#xAE; siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 240,000 shares of its common stock at a purchase price of $2.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 240,000 shares of common stock. The warrants will have an exercise price of $2.00 per share, will be exercisable upon issuance and expire five years following the date of issuance. The closing of the offering is expected to occur on or about December 24, 2024, subject to the satisfaction of customary closing conditions.
H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.
The aggregate gross proceeds to the Company from the offering are expected to be $0.48 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.

News

Offerings

PHIO

Phio Pharmaceuticals Has Entered Into Definitive Agreements For The Purchase And Sale Of An Aggregate Of 240K Shares At A Price Of $2.00 Per Share In A Registered Direct Offering, For Gross Proceeds Of $0.48M

Innodata's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NYSE">INOD</a>) short percent of float has risen 12.5% since its last report. The company recently reported that it has 2.77 million shares sold short, which is 10.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.39 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Innodata Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734977720_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Innodata has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Innodata's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Innodata's peer group average for short interest as a percentage of float is 2.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

INOD

(INOD) - Analyzing Innodata's Short Interest

WR Berkley's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) short percent of float has fallen 13.25% since its last report. The company recently reported that it has 3.95 million shares sold short, which is 1.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>WR Berkley Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734977716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WR Berkley has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing WR Berkley's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, WR Berkley's peer group average for short interest as a percentage of float is 1.88%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(WRB) - Analyzing WR Berkley's Short Interest

President-elect Donald Trump has openly condemned President Joe Biden for selling off portions of the southern border wall between the United States and Mexico at incredibly low costs, referring to the action as an &#8220;almost criminal act.&#8221; Speaking from his <a href="https://www.benzinga.com/news/24/12/42430557/elon-musk-refutes-rumors-of-buying-property-near-donald-trumps-mar-a-lago-im-not-buying-or-building-a-house-anywhere">Mar-a-Lago residence</a> in Florida, Trump urged Biden to immediately halt the sales, arguing that the materials are critical for his incoming administration's plans to finish building the wall.
&#8220;They're selling it for five cents on the dollar, knowing we're going to need it,&#8221; Trump said during a press conference. &#8220;It's very expensive now – double what it was six years ago. If we don't have it, we'll have to rebuild, costing taxpayers hundreds of millions of dollars.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">President Trump on the Biden administration selling off sections of his border wall: &quot;Now it&#39;s about double the price of what it would&#39;ve been six years ago, and the administration is trying to sell it for five cents on the dollar&#8230; It&#39;s almost a criminal act.&quot; <a href="https://t.co/F4PHAe1G9Z">pic.twitter.com/F4PHAe1G9Z</a>
&mdash; Trump War Room (@TrumpWarRoom) <a href="https://twitter.com/TrumpWarRoom/status/1868696693770002484?ref_src=twsrc%5Etfw">December 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
<h2 class="wp-block-heading">What's Going On?</h2>
Reports indicate that unused portions of the border wall are being auctioned through GovPlanet, a government surplus equipment marketplace. <a href="https://x.com/realDailyWire/status/1867257767641174408">Videos</a> shared by The Daily Wire on Dec. 12 show trucks moving wall parts from Arizona border stations. Border patrol agents say they're clearing out these materials before Christmas and &#8220;taking it from three stations: Nogales, Tucson and Three Points.&#8221;&nbsp;
&#8220;I'm asking today, Joe Biden, to please stop selling the wall. We're going to use that to create a strong barrier,&#8221; Trump pleaded.&nbsp;
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
This disposal follows the <a href="https://www.benzinga.com/markets/cannabis/24/03/37898972/congress-discusses-remaining-fy2024-spending-bill-with-provisions-on-cannabis-sales-and-psychede">2024 National Defense Authorization Act</a>, which mandated the sale, transfer or donation of unused materials to reduce storage costs. While some materials were sent to Texas and California for repairs, others were sold through auctions. According to a Biden administration official who spoke to USA Today, auctioning the materials was the most economical option. He also said the government loses legal custody of the assets after selling them.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">EXCLUSIVE: Weeks before Trump takes office, Biden is racing to auction off unused border wall materials. Video shows trucks hauling wall materials off the border to a government auction site, where a massive amount of wall is waiting to be sold. <a href="https://t.co/ogaQMBHw7R">pic.twitter.com/ogaQMBHw7R</a>
&mdash; Daily Wire (@realDailyWire) <a href="https://twitter.com/realDailyWire/status/1867257767641174408?ref_src=twsrc%5Etfw">December 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Trump, who plans to rebuild and expand the border wall during his second term, has called the sales a direct attack on his agenda. "They know we're going to use it," Trump said, accusing the Biden administration of deliberately sabotaging his plans. "Just think about how ridiculous it is."
<h2 class="wp-block-heading">The Political Blame Game</h2>
This latest clash over the border wall highlights ongoing tensions between the two administrations. In February, <a href="https://www.benzinga.com/news/24/02/37061857/trump-will-be-held-accountable-every-day-between-now-and-november-for-sabotaging-border-deal-says-bi">Biden shifted the blame</a> for the border crisis to Trump, accusing him and his allies of derailing a bipartisan border security plan. "The only reason the border is not secure is Donald Trump and his MAGA Republican friends," Biden said in a statement at the time.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Donald Trump Claims That Biden Is Selling Off Parts Of The Border Wall 'For Five Cents On The Dollar' And Urges Him To Stop

Associated Cap Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>) short percent of float has risen 21.21% since its last report. The company recently reported that it has 8 thousand shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Associated Cap Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734977710_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Associated Cap Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Associated Cap Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Associated Cap Gr's peer group average for short interest as a percentage of float is 2.50%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Associated Cap Gr?

The House Ethics Committee's report found former Rep. <a href="https://www.benzinga.com/topic/matt-gaetz" target="_blank" rel="noopener">Matt Gaetz</a> (R), who <a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation" target="_blank" rel="noopener">was initially picked</a> by President-elect Donald Trump to be Attorney General, had allegedly paid tens of thousands of dollars to women, including a 17-year-old girl, for sex or drugs, according to the report, obtained by CNN.
The bombshell document, released Monday, <a href="https://www.cnn.com/2024/12/23/politics/matt-gaetz-house-ethics-report/index.html">alleges</a> that Gaetz had, on at least 20 occasions, violated Florida state laws, including the statutory rape law.
"The Committee determined there is substantial evidence that Representative Gaetz violated House Rules and other standards of conduct prohibiting prostitution, statutory rape, illicit drug use, impermissible gifts, special favors or privileges, and obstruction of Congress," the House Ethics panel investigators wrote. 
What Happened: Shortly after Trump chose Gaetz for the AG job and he<a href="https://www.benzinga.com/news/24/11/42024613/lawyer-ethics-committee-witness-says-she-saw-ag-nominee-gaetz-having-sex-with-a-minor" target="_blank" rel="noreferrer noopener">&nbsp;resigned from Congress</a>, rumors began to swirl about the Florida Rep's behavior and that he was under investigation by the House Ethics Committee for allegations of sexual misconduct, drug use and more.
Once Gaetz was no longer a member of Congress, the Ethics Committee ostensibly had no jurisdiction over him, which is why CNN referred to the committee making the report public to be a "rare step of releasing a report about a former member who resigned from Congress."
Gaetz, who refused to answer most committee questions alleging bias and leaks by the Ethics Committee, allegedly organized sexual encounters with women through the dating website SeekingArrangement.com, according to the report.
<h2 class="wp-block-heading">Improper Use of House Resources: Bahamas Trip</h2>
While a member of Congress, noted the report, Gaetz allegedly set up a pseudonymous email account from his House office to buy weed. The report claims he also helped a woman obtain a passport by using his chief of staff and falsely stating she was a constituent.
Read Also: <a href="https://www.benzinga.com/politics/24/11/42170037/elon-musk-said-matt-gaetz-would-be-hammer-of-justice-as-attorney-general-former-congressman-now-unemployed-sells-cameos-for-500">Elon Musk Said Matt Gaetz Would Be &#8216;Hammer Of Justice&#8217; As Attorney General: Former Congressman Now Unemployed, Sells Cameos For $500</a>
In terms of illicit drug use, the committee found that Gaetz allegedly used cocaine, ecstasy and cannabis between 2017 and 2019. Investigators also focused on a 2018 trip to the Bahamas – which they said "violated the House gift rule" – during which he "engaged in sexual activity" with multiple women, including one who described the trip itself as "the payment" for sex on the trip.
Gaetz denied allegations of statutory rape, characterizing his relationships as consensual dating, according to CNN. He explained the payments made via PayPal, Venmo, and CashApp as acts of generosity. The committee's report alleged that Gaetz's then-girlfriend often facilitated arrangements and participated in sexual encounters.
"In my single days, I often sent funds to women I dated &#8211; even some I never dated but who asked. I dated several of these women for years," Gaetz said in a statement on X last week after CNN reported that the committee had voted to release the report. "It's embarrassing, though not criminal, that I probably partied, womanized, drank and smoked more than I should have earlier in life. I live a different life now," Gaetz said.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42187962/step-inside-matt-gaetzs-2-7m-childhood-mansion-the-real-life-set-of-the-truman-show">Step Inside Matt Gaetz&#8217;s $2.7M Childhood Mansion – The Real-Life Set Of &#8216;The Truman Show&#8217;</a></li>
</ul>
Photo: Shutterstock

Cannabis

Government

Politics

House Ethics Committee Alleges Matt Gaetz Violated Laws, Releases Report On Misconduct

WIIM

Walmart shares are trading lower after the Consumer Financial Protection Bureau sued Walmart and Branch Messenger for forcing delivery drivers to use costly deposit accounts to get paid and for deceiving workers.

New Horizon Aircraft Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock is trading higher on Monday after the company, on Friday, announced it received an $8.4 million investment from a strategic investor and aerospace supporter. Here&#8217;s what you <a href="https://www.benzinga.com/pressreleases/24/12/g42628909/horizon-aircraft-secures-8-4-million-strategic-investment">need to know</a>.
What To Know: The investment will fortify Horizon Aircraft&#8217;s balance sheet, provide stability in the operations, governance and regulatory priorities and fund further development and flight testing of its hybrid eVTOL, the Cavorite X7.
The $8.4 million investment will consist of $2.1 million in Horizon shares, equivalent to 4,166,667 shares, and $6.3 million in preferred shares, representing 4,500 preferred shares.
Brandon Robinson, CEO and Co-Founder of Horizon Aircraft said, &#8220;We are deeply appreciative for this second investment from our strategic partner. The principle&#8217;s continued support through this second tranche of funding provides our business with a solid working capital position in support of our initiatives. With this commitment Horizon Aircraft is on solid footing, and our focus is on the development of our full-scale hybrid eVTOL.&#8221;
How To Buy New Horizon Stock
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in New Horizon Aircraft's case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
See Also: <a href="https://www.benzinga.com/insights/options/24/12/42652946/check-out-what-whales-are-doing-with-iren">Check Out What Whales Are Doing With IREN</a>
HOVR Price Action: At the time of publication, New Horizon stock is trading 26.8% higher at 78 cents, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Image via Wikimedia Commons

Movers

HOVR

What's Going On With New Horizon Stock Monday?

Analyst Ratings

NBC Halftime Report Final Trades: Zoom Communications, Lockheed Martin, iShares Russell 1000 Value ETF

In the last three months, 6 analysts have published ratings on Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $68.0, a high estimate of $70.00, and a low estimate of $64.00. Experiencing a 4.67% decline, the current average is now lower than the previous average price target of $71.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976859_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Winnebago Industries. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$64.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Tristan Thomas-Martin</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Winnebago Industries. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Winnebago Industries compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Winnebago Industries's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Winnebago Industries's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WGO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Winnebago Industries analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Winnebago Industries's Background</h2>
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.
<h3>A Deep Dive into Winnebago Industries's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Winnebago Industries's revenue growth over a period of 3 months has faced challenges. As of 31 August, 2024, the company experienced a revenue decline of approximately -6.5%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Winnebago Industries's net margin excels beyond industry benchmarks, reaching -4.04%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Winnebago Industries's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.25% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Winnebago Industries's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.21% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Winnebago Industries's debt-to-equity ratio is below the industry average at 0.58, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Winnebago Industries: Insights From 6 Financial Analysts

12 analysts have shared their evaluations of Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Waters and provided 12-month price targets. The average target is $380.83, accompanied by a high estimate of $430.00 and a low estimate of $325.00. This current average reflects an increase of 10.53% from the previous average price target of $344.55. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976853_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Waters among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$430.00</td>
<td>-</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$430.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Justin Bowers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$325.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Eve Burstein</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$360.00</td>
<td>$345.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$410.00</td>
<td>$363.00</td>
</tr>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$360.00</td>
<td>$332.00</td>
</tr>
<tr>
<td>Rachel Vatnsdal</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$380.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$415.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$360.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$330.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$415.00</td>
<td>$355.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$355.00</td>
<td>$335.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Waters. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Waters compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Waters's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Waters's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WAT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Waters analyst ratings.</a>
<h2>All You Need to Know About Waters</h2>
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
<h3>Financial Insights: Waters</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Waters showcased positive performance, achieving a revenue growth rate of 4.02% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.82%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Waters's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.71% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Waters's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 1.19, Waters faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Waters Stock

Throughout the last three months, 39 analysts have evaluated Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">11</td>
<td align="right">7</td>
<td align="right">21</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.72, a high estimate of $110.00, and a low estimate of $70.00. Experiencing a 2.77% decline, the current average is now lower than the previous average price target of $88.16. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976840_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Nike by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Komp</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Jim Duffy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$75.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$74.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$84.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$80.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Michael Binetti</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$97.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$82.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$93.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$95.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Announces</td>
<td>Buy</td>
<td>$84.00</td>
<td>-</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$73.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$97.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$77.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$96.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$82.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Michael Binetti</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$83.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Randal Konik</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$85.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$82.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$85.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Nike. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Nike compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Nike's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Nike's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NKE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Nike analyst ratings.</a>
<h2>All You Need to Know About Nike</h2>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
<h3>Nike's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3 months period, Nike showcased positive performance, achieving a revenue growth rate of 6.6% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Nike's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Nike's ROE excels beyond industry benchmarks, reaching 8.31%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Nike's ROA stands out, surpassing industry averages. With an impressive ROA of 3.07%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 0.86, Nike faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Nike's Future

In the last three months, 18 analysts have published ratings on Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $191.72, a high estimate of $220.00, and a low estimate of $164.00. This upward trend is apparent, with the current average reflecting a 4.43% increase from the previous average price target of $183.59.
<img src="https://www.benzinga.com/files/images/story/2024/1734976826_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Darden Restaurants is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$209.00</td>
<td>$193.00</td>
</tr>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$211.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Brian Bittner</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$205.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$206.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Eric Gonzalez</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$194.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Nick Setyan</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$165.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$183.00</td>
<td>-</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$206.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Darden Restaurants. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darden Restaurants compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Darden Restaurants's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Darden Restaurants's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DRI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Darden Restaurants analyst ratings.</a>
<h2>Unveiling the Story Behind Darden Restaurants</h2>
Darden Restaurants is the largest restaurant operator in the us full-service space, with consolidated revenue of $11.4 billion in fiscal 2024 resulting in 3%-4% full-service market share (per NRA data and our calculations). The company maintains a portfolio of 10 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, and The Capital Burger. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2024, the company operated 2,031 restaurants in the us.
<h3>Financial Milestones: Darden Restaurants's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining Darden Restaurants's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.82% as of 30 November, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Darden Restaurants's net margin is impressive, surpassing industry averages. With a net margin of 7.44%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Darden Restaurants's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 10.21%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Darden Restaurants's ROA stands out, surpassing industry averages. With an impressive ROA of 1.8%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Darden Restaurants's debt-to-equity ratio is below the industry average. With a ratio of 3.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Darden Restaurants's Future

Truist Finl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) short percent of float has risen 41.67% since its last report. The company recently reported that it has 17.98 million shares sold short, which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Truist Finl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976824_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Truist Finl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Truist Finl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Truist Finl's peer group average for short interest as a percentage of float is 3.74%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(TFC) - Analyzing Truist Finl's Short Interest

American Superconductor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NYSE">AMSC</a>) short percent of float has fallen 8.05% since its last report. The company recently reported that it has 2.64 million shares sold short, which is 6.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.25 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>American Superconductor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976818_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for American Superconductor has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing American Superconductor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, American Superconductor's peer group average for short interest as a percentage of float is 10.11%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AMSC

Looking Into American Superconductor's Recent Short Interest

RAPT Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) shares are trading higher after the company disclosed a partnership with Shanghai Jemincare Pharmaceutical.
The collaboration is for an exclusive license agreement to develop and commercialize RPT904, a novel anti-IgE monoclonal antibody worldwide, excluding mainland <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42643847/rapt-therapeutics-and-shanghai-jemincare-pharmaceutical-announce-exclusive-license-agreement-for-n" rel="noreferrer noopener">China, Hong Kong, Macau, and Taiwan</a>.
RPT904 is designed to provide a potential alternative to omalizumab (Xolair), addressing allergic conditions such as asthma and chronic spontaneous urticaria (CSU).
As per the deal, Jemincare will receive a $35 million upfront payment, up to $672.5 million in regulatory and commercial milestone payments, and royalties on sales outside the Jemincare Territory.
RAPT plans to focus on developing RPT904 for food allergies, while Jemincare is conducting Phase 2 trials in China for asthma and CSU.
Jemincare has completed a Phase 1 study of JYB1904 in 56 healthy volunteers in China, evaluating safety, pharmacokinetics (PK), and pharmacodynamics (PD).
Jemincare is now running two Phase 2 trials in China. The asthma trial focuses on PK and PD comparisons with omalizumab, with topline data expected in late 2025. The CSU trial targets safety and efficacy, with results anticipated in early 2026.
Brian Wong, M.D., Ph.D., President and CEO of RAPT said, &#8220;We&#8217;re delighted to partner with Jemincare and excited by RPT904 and its potential to be a novel best-in-class treatment option for patients with food allergy. Omalizumab&#8217;s rapid uptake in food allergy since its approval earlier this year confirms the high unmet need and large opportunity in this growing market.&#8221;
&#8220;RPT904 targets the same clinically validated epitope as omalizumab and combined with extended half-life, gives this molecule a best-in-class profile. We plan to initiate a Phase 2b clinical trial of RPT904 in food allergy in the second half of 2025.&#8221;
In a separate release, RAPT Therapeutics disclosed a securities purchase agreement with accredited investors for a private <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42644085/rapt-therapeutics-announces-150-million-private-placement" rel="noreferrer noopener">placement valued at around $150 million</a>.
The agreement includes 100 million common shares priced at $0.85 each and pre-funded warrants for up to 76.45 million shares priced at $0.8499 each.
The pre-funded warrants, exercisable at $0.0001 per share, are immediately exercisable and remain valid until fully exercised.
The transaction is expected to close by December 27, 2024, pending customary conditions.
Price Action: RAPT shares are up 110.2% at $1.735 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42647650" target="_blank" rel="noreferrer noopener">Palantir Vs. Lockheed: A Tech-Fueled Showdown In The $850 Billion Defense Market</a></li>
</ul>

Equities

Financing

Contracts

Small Cap

RAPT

Why RAPT Therapeutics Stock Gained Over 100% On Monday?

Analysts' ratings for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) over the last quarter vary from bullish to bearish, as provided by 14 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $293.29, a high estimate of $315.00, and a low estimate of $265.00. Highlighting a 0.58% decrease, the current average has fallen from the previous average price target of $295.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976812_0_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Danaher by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$265.00</td>
<td>-</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Doug Schenkel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$285.00</td>
<td>-</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$311.00</td>
<td>$333.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$315.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Paul Knight</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$310.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Jacob Johnson</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$265.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Dan Leonard</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$305.00</td>
<td>$309.00</td>
</tr>
<tr>
<td>Andrew Cooper</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$277.00</td>
<td>$278.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$278.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Jacob Johnson</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$315.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Danaher. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Danaher compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Danaher's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Danaher's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DHR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Danaher analyst ratings.</a>
<h2>Delving into Danaher's Background</h2>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
<h3>Breaking Down Danaher's Financial Performance</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Danaher's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 3.09%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Danaher's net margin excels beyond industry benchmarks, reaching 14.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Danaher's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.62% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Danaher's ROA excels beyond industry benchmarks, reaching 1.03%. This signifies efficient management of assets and strong financial health.
Debt Management: Danaher's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.34.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

14 Analysts Have This To Say About Danaher

Sunrun's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NYSE">RUN</a>) short percent of float has risen 3.82% since its last report. The company recently reported that it has 48.18 million shares sold short, which is 25.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sunrun Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976812_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sunrun has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Sunrun's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sunrun's peer group average for short interest as a percentage of float is 9.32%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Sunrun?

Happy Holidays, everyone!
I hope this newsletter finds you in great spirits, enjoying the festive season with your loved ones. This year, Christmas coincides with the first day of Hanukkah, a rare alignment that adds even more reason to celebrate.
While Thanksgiving remains my favorite holiday, Christmas holds a special place in my heart, and today, I want to give you a gift that will resonate well into 2025 and beyond: a roadmap to becoming a better investor by exploring a highly underappreciated corner of the market – community bank stocks.
Now, before you roll your eyes and declare this the dullest idea ever, let me assure you: while index funds and flashy AI stocks dominate headlines, community banks represent one of the few remaining inefficiencies in today's highly efficient market.
Let me show you.
In fact, Charlie Munger himself hinted at this path during a meeting years ago. He emphasized the need to seek opportunities in less-liquid, inefficient markets, areas where institutional investors fear to tread. This, my friends, describes community banks to a tee.
<h2 class="wp-block-heading">My Journey into Bank Stocks</h2>
My introduction to community bank stocks came about almost by accident while I was working for a small regional firm in Annapolis, Maryland.
This firm specialized in making markets for community banks and trading municipal bonds. A colleague in our office, a local legend of sorts, always seemed to have the Midas touch. He would stroll in at 9:29 a.m., just before the market opened, and was out the door well before happy hour began. Despite this seemingly casual approach, he was incredibly successful, with clients who were fiercely loyal to him.
Curious about his secret, I asked him one day how he managed to achieve such stellar results. His answer was simple but eye-opening: he traded local bank stocks.
This was back in the days before Regulation FD, when trading volumes were thin, and spreads were wide. A stock might be quoted at 10 bid and 12 offered. With a solid trading desk, you could buy at 10, sell at 12, and pocket the difference.
It was a lucrative business.
But the real magic came during the aftermath of the S&amp;L crisis in the early 1990s. These bank stocks often traded at 40%, 50%, or 60% of tangible book value. Then came the Riegle-Neal Interstate Banking and Branching Efficiency Act of 1994, which kicked off a wave of banking consolidation. Larger banks started snapping up smaller ones at premiums to book value.
Suddenly, these undervalued stocks became acquisition targets, creating significant returns for investors.
That's when I realized the immense potential in community bank stocks, a fascination that has stayed with me ever since.
<h2 class="wp-block-heading">Why Community Banks?</h2>
Let's start with the backdrop.
Community banks have been consolidating for decades, and the trend is far from over. We've gone from roughly 18,000 banks in the 1980s to about 5,000 today, yet that number is still too high for the industry to function efficiently.
Scale matters in banking. Larger banks enjoy better returns on assets, higher returns on equity, and a lower cost of regulatory compliance. This creates a continuous cycle of mergers and acquisitions, with about 4% of banks being acquired annually over the past 20 years.
Recent years have seen this pace slow, largely due to the anti-M&amp;A stance of the Biden administration. Lengthy deal approvals and increased regulatory scrutiny have held back consolidation, but this has created significant pent-up demand.
With regulatory conditions poised to become more favorable, the pace of M&amp;A activity is likely to accelerate, setting the stage for significant opportunities in the sector.
<h2 class="wp-block-heading">The Double Compounding Opportunity</h2>
Community bank stocks often trade below tangible book value, creating a margin of safety for investors.
Currently average around 1.28 times book value, but during peak M&amp;A cycles, multiples can reach as high as 1.75 or even 2 times book. This sets up a double-compounding scenario where book values grow as securities portfolios recover, and takeover multiples increase.
Here's the kicker: many of these banks are well-capitalized, profitable, and run by disciplined management teams. They're sitting ducks for larger, better-capitalized banks looking to expand their market footprint or diversify their loan portfolios.
The inefficiencies in this market are staggering, and investors willing to do the work can reap outsized rewards.
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24?utm_source=WebRD-1223">65% Off Benzinga Edge – Sale Ends December 31!</a>
<h2 class="wp-block-heading">Four Community Banks to Watch</h2>
1. Eagle Bancorp (EGBN): Based in Bethesda, Maryland, Eagle Bancorp operates in the lucrative Washington, D.C. market. The stock trades at just 70% of tangible book value, primarily due to concerns over commercial real estate exposure. However, the bank's portfolio leans toward higher-quality assets, and its market position in D.C. makes it an attractive acquisition target. With plenty of capital and a healthy 5.57% dividend yield, EGBN is a textbook example of value waiting to be unlocked.
2. Capitol Federal Financial (CFFN): Operating out of Topeka, Kansas, this is the epitome of a conservative bank. With 80% of its loans in single-family mortgages and non-performing assets at just 0.11% of total assets, CFFN is rock-solid. It trades at 79% of tangible book value and offers a 5.56% dividend yield. Insiders have been buying, and the bank's capital position is among the best in its peer group. This is the kind of quiet, sleepy bank that makes for an ideal acquisition target.
3. RBB Bancorp (RBB): Royal Business Bank, based in Los Angeles, serves a niche market within the Asian-American community. Its branches span strategic locations, including D.C., Chicago, Las Vegas, and Hawaii. With a strong loan portfolio and loyal deposits, RBB trades at 93% of tangible book value and offers a 2.98% dividend yield. This bank's focused strategy and profitability make it a highly attractive target for consolidation.
4. Northfield Bank (NFBK): Headquartered on Staten Island, Northfield operates 38 branches across the New York area. It trades at 75% of tangible book value and pays a 4.35% dividend. Despite past acquisition talks falling through, the bank's solid fundamentals and prime location ensure it remains a viable target. Non-performing assets are just 0.57%, underscoring its financial health and operational efficiency.
The Road Ahead
The inefficiencies in the community banking sector make it one of the last bastions of true value investing. As M&amp;A activity picks up and interest rates stabilize, the opportunity to profit from these overlooked gems will only grow. The double-compounding effect of increasing book values and higher takeover multiples could generate returns that far outpace the broader market.
So, this holiday season, consider giving yourself the gift of patience and discipline. Ignore the noise of instant experts and trendy stocks. Instead, focus on the quiet, undervalued corners of the market where real wealth is built. Community bank stocks may not be glamorous, but they offer something far more valuable: the potential for outsized, long-term gains.
Happy Holidays, and here's to a prosperous 2025!
Transform your trading strategy with Benzinga Edge. Get exclusive stock picks, daily trade setups, and real-time alerts. Last chance to save 65%—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24?utm_source=WebRD-1223">Don't miss the End-of-Year Sale before it's gone!</a>
Photo by Yiorgos Ntrahas for Unsplash

Comments

Medley Management

Medley Management (MDLM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga